| 1. |
Gether L, Overgaard LK, Egeberg A, et al. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol, 2018, 179(2): 282-289.
|
| 2. |
Mohd Mustapa MF, Exton LS, Bell HK, et al. Updated guidance for writing a British Association of Dermatologists clinical guideline: the adoption of the GRADE methodology 2016. Br J Dermatol, 2017, 176(1): 44-51.
|
| 3. |
Hampton PJ, Berth-Jones J, Duarte Williamson CE, et al. British Association of Dermatologists guidelines for the management of people with rosacea 2021. Br J Dermatol, 2021, 185(4): 725-735.
|
| 4. |
Melnik BC. Rosacea: The blessing of the Celts - an approach to pathogenesis through translational research. Acta Derm Venereol, 2016, 96(2): 147-156.
|
| 5. |
中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南(2021版). 中华皮肤科杂志, 2021, 54(4): 279-288.
|
| 6. |
李吉, 谢红付. 玫瑰痤疮的定义及分型. 皮肤病与性病, 2017, 39(2): 89-90.
|
| 7. |
Reinholz M, Ruzicka T, Steinhoff M, et al. Pathogenesis and clinical presentation of rosacea as a key for a symptom-oriented therapy. J Dtsch Dermatol Ges, 2016, 14 (Suppl 6): 4-15.
|
| 8. |
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识(2016). 中华皮肤科杂志, 2017, 50(3): 156-161.
|
| 9. |
Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol, 2018, 78(1): 148-155.
|
| 10. |
López-Valverde G, Garcia-Martin E, Larrosa-Povés JM, et al. Therapeutical management for ocular rosacea. Case Rep Ophthalmol, 2016, 7(1): 237-242.
|
| 11. |
Two AM, Wu W, Gallo RL, et al. Rosacea: part Ⅱ. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol, 2015, 72(5): 761-770.
|
| 12. |
许阳, 骆丹. 中外玫瑰痤疮治疗指南与共识解读. 中华皮肤科杂志, 2018, 51(11): 836-839.
|
| 13. |
Juliandri J, Wang X, Liu Z, et al. Global rosacea treatment guidelines and expert consensus points: The differences. J Cosmet Dermatol, 2019, 18(4): 960-965.
|
| 14. |
吴琰瑜, 章伟. 玫瑰痤疮药物治疗进展. 国际皮肤性病学杂志, 2016, 42(5): 393-396.
|
| 15. |
Garden BC, Garden JM, Goldberg DJ. Light-based devices in the treatment of cutaneous vascular lesions: an updated review. J Cosmet Dermatol, 2017, 16(3): 296-302.
|
| 16. |
Kim M, Kim J, Jeong SW, et al. Long-pulsed 1064-nm Nd: YAG laser ameliorates LL-37-induced rosacea-like skin lesions through promoting collagen remodeling in BALB/c mice. Lasers Med Sci, 2018, 33(2): 393-397.
|
| 17. |
Jones IT, Guiha I, Fabi SG. Open-label study assessing the efficacy and tolerability of topical skincare and sun protection products following intense pulsed light treatment. J Cosmet Dermatol, 2018, 17(3): 441-447.
|
| 18. |
Meesters AA, van der Linden MM, De Rie MA, et al. Fractionated carbon dioxide laser therapy as treatment of mild rhinophyma: report of three cases. Dermatol Ther, 2015, 28(3): 147-150.
|
| 19. |
Del Rosso JQ, Diane T, Richard G, et al. Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care. Cutis, 2013, 92(5): 234-240.
|
| 20. |
赵梓刚, 李承新. 玫瑰痤疮的非药物治疗. 皮肤病与性病, 2017, 39(2): 96-98.
|
| 21. |
郭宏佐, 张钰汇, 孙艳, 等. 中国人玫瑰痤疮患病率的Meta分析. 中国循证医学杂志, 2019, 19(5): 543-549.
|
| 22. |
Kim SJ, Lee Y, Seo YJ, et al. Comparative efficacy of radiofrequency and pulsed dye laser in the treatment of rosacea. Dermatol Surg, 2017, 43(2): 204-209.
|
| 23. |
Baldwin H, Santoro F, Lachmann N, et al. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin. J Cosmet Dermatol, 2019, 18(6): 1686-1692.
|
| 24. |
Deaver Peterson J, Katz TM. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy. J Cosmet Dermatol, 2019, 18(6): 1758-1764.
|
